These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 2042398

  • 1. Simultaneous expression of the Lassa virus N and GPC genes from a single recombinant vaccinia virus.
    Morrison HG, Goldsmith CS, Regnery HL, Auperin DD.
    Virus Res; 1991 Mar; 18(2-3):231-41. PubMed ID: 2042398
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection.
    Auperin DD, Esposito JJ, Lange JV, Bauer SP, Knight J, Sasso DR, McCormick JB.
    Virus Res; 1988 Feb; 9(2-3):233-48. PubMed ID: 3354260
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Baculovirus expression of the glycoprotein gene of Lassa virus and characterization of the recombinant protein.
    Hummel KB, Martin ML, Auperin DD.
    Virus Res; 1992 Sep 01; 25(1-2):79-90. PubMed ID: 1413995
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus.
    Yasuda A, Kimura-Kuroda J, Ogimoto M, Miyamoto M, Sata T, Sato T, Takamura C, Kurata T, Kojima A, Yasui K.
    J Virol; 1990 Jun 01; 64(6):2788-95. PubMed ID: 2159544
    [Abstract] [Full Text] [Related]

  • 12. Expression of envelope glycoprotein (E) of Japanese encephalitis virus by recombinant vaccinia virus.
    Haishi S, Imai H, Hirai K, Igarashi A, Kato S.
    Acta Virol; 1989 Dec 01; 33(6):497-503. PubMed ID: 2576591
    [Abstract] [Full Text] [Related]

  • 13. Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever.
    Saijo M, Georges-Courbot MC, Marianneau P, Romanowski V, Fukushi S, Mizutani T, Georges AJ, Kurata T, Kurane I, Morikawa S.
    Clin Vaccine Immunol; 2007 Sep 01; 14(9):1182-9. PubMed ID: 17634509
    [Abstract] [Full Text] [Related]

  • 14. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P, Parker M, Ludwig GV, Davis NL, Johnston RE, Smith JF.
    Virology; 1997 Dec 22; 239(2):389-401. PubMed ID: 9434729
    [Abstract] [Full Text] [Related]

  • 15. Expression of feline immunodeficiency virus (FIV) gag gene in vaccinia virus vector.
    Wojcik J.
    Acta Microbiol Pol; 1995 Dec 22; 44(2):191-6. PubMed ID: 8906935
    [Abstract] [Full Text] [Related]

  • 16. A vaccine based on recombinant modified Vaccinia Ankara containing the nucleoprotein from Lassa virus protects against disease progression in a guinea pig model.
    Kennedy EM, Dowall SD, Salguero FJ, Yeates P, Aram M, Hewson R.
    Vaccine; 2019 Aug 23; 37(36):5404-5413. PubMed ID: 31331770
    [Abstract] [Full Text] [Related]

  • 17. Vaccinia virus: a selectable eukaryotic cloning and expression vector.
    Mackett M, Smith GL, Moss B.
    Proc Natl Acad Sci U S A; 1982 Dec 23; 79(23):7415-9. PubMed ID: 6296831
    [Abstract] [Full Text] [Related]

  • 18. Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice.
    Wild TF, Bernard A, Spehner D, Drillien R.
    J Gen Virol; 1992 Feb 23; 73 ( Pt 2)():359-67. PubMed ID: 1538193
    [Abstract] [Full Text] [Related]

  • 19. One hundred base pairs of 5' flanking sequence of a vaccinia virus late gene are sufficient to temporally regulate late transcription.
    Bertholet C, Drillien R, Wittek R.
    Proc Natl Acad Sci U S A; 1985 Apr 23; 82(7):2096-100. PubMed ID: 3856886
    [Abstract] [Full Text] [Related]

  • 20. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection.
    Mason PW, Pincus S, Fournier MJ, Mason TL, Shope RE, Paoletti E.
    Virology; 1991 Jan 23; 180(1):294-305. PubMed ID: 1845826
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.